-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 C3OcNEGKqg1y0VHYqnImPYRlVMm873sMvvhqIHJhPBruVZViTHWuNeGO3T2oPtzj
 6thleOJ+wGo6KK3W1nfH8g==

<SEC-DOCUMENT>0001144204-07-017761.txt : 20070406
<SEC-HEADER>0001144204-07-017761.hdr.sgml : 20070406
<ACCEPTANCE-DATETIME>20070406162636
ACCESSION NUMBER:		0001144204-07-017761
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20070402
ITEM INFORMATION:		Entry into a Material Definitive Agreement
FILED AS OF DATE:		20070406
DATE AS OF CHANGE:		20070406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		07754639

	BUSINESS ADDRESS:	
		STREET 1:		323 VINTAGE PARK DRIVE, SUITE B
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6502122568

	MAIL ADDRESS:	
		STREET 1:		323 VINTAGE PARK DRIVE, SUITE B
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v071018_8k.htm
<TEXT>
<html>
  <head>
    <title>
</title>
</head>
  <body bgcolor="#ffffff">
    <div>
      <div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div>
            <hr style="COLOR: black" align="left" noshade size="2" width="100%">
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 14pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>SECURITIES
          AND EXCHANGE COMMISSION </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>WASHINGTON,
          D.C. 20549 </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;

          <div>
            <hr style="COLOR: black" align="center" noshade size="2" width="15%">
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 16pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>FORM
          8-K</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>CURRENT
          REPORT </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>Pursuant
          to Section 13 or 15(d) of the </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>Securities
          Exchange Act of 1934 </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>Date
          of report (Date of earliest event reported): April 2, 2007</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;

          <div>
            <hr style="COLOR: black" align="center" noshade size="2" width="15%">
          </div>
          <div>&#160;</div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><img src="logo.jpg" alt=""><font style="DISPLAY: inline; FONT-SIZE: 14pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(Exact
          name of registrant as specified in Charter) </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">

              <tr>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>Delaware</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="2%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                </td>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>0-8092</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="2%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                </td>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>94-1620407</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
                </td>
              </tr>
              <tr>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(State
                    or other jurisdiction of</strong></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>incorporation
                    or organization)</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="2%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                </td>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(Commission
                    File No.)</strong></font></div>
                </td>
                <td align="left" valign="bottom" width="2%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                </td>
                <td valign="top" width="32%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(IRS
                    Employee Identification
                    No.)</strong></font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>323
          Vintage Park Drive, Suite B, Foster City, California 94404</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(Address
          of Principal Executive Offices) </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>650-212-2568</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>(Issuer
          Telephone number) </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;

          <div>
            <hr style="COLOR: black" align="left" noshade size="2" width="100%">
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Check
          the appropriate box below if the Form 8-K filing is intended to simultaneously
          satisfy the filing obligation of the registrant under any of the following
          provisions (see General Instruction A.2. below):</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">[
          ] Written communications pursuant to Rule 425 under the Securities Act
          (17 CFR
          230.425)</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">[
          ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
          CFR
          240.14a-12)</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">[
          ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
          Act (17 CFR 240.14d-2(b))</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">[
          ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
          Act (17 CFR 240.13e-4(c))</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div><br>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Item
          1.01<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Entry
          into a Material Definitive Agreement.</strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
          April
          2, 2007, we entered into an Amended and Restated Exclusive License Agreement
          with Alteon, Inc. (&#8220;Alteon&#8221;), under which we have granted Alteon worldwide
          exclusive rights to a family of orally bioavailable organoselenium compounds
          that have demonstrated potent anti-oxidant and anti-inflammatory properties
          in
          clinical and preclinical studies. Previously, we were a party to a license
          agreement dated September 28, 2004 with HaptoGuard, Inc., which was subsequently
          acquired by Alteon. The amended and restated exclusive license agreement
          supercedes and replaces our prior agreement with HaptoGuard. The new agreement
          expands the scope of the original agreement to also include non-cardiovascular
          indications.&#160;</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under
          the
          new agreement, Alteon agreed to invest a minimum of $7.5 million over a
          three
          year period following the effective date of the agreement, in its development
          program for the development, discovery and manufacture of licensed products
          based on the processes and compounds covered under the license. Alteon
          agreed to
          pay us a non-refundable sum of $500,000, payable in six monthly installments
          of
          $50,000, with the remaining $200,000 payable upon&#160;the closing of a
          financing of Alteon approved by Alteon<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8217;</font>s shareholders.
          The agreement also provides for milestone payments to us upon certain
          significant milestone events in the development of a potential drug product.
          The
          agreement also entitles us to various levels of sublicensing fees and royalties
          based on a percentage of net sales of the licensed product. </font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
          a part
          of the agreement, Alteon agreed to make an equity investment in our common
          stock, at a per-share price equal to 125% of the trading price on the trading
          day immediately prior to such purchase, and no less than $0.24 per share,
          resulting in net proceeds to us of $500,000. </font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          agreement is terminable for cause by either party, by Alteon with or without
          cause with 180 days&#8217; prior written notice, or by us if Alteon does not make
          timely payments under the license. </font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
          amended and restated agreement will be filed as an exhibit to our Quarterly
          Report on Form 10-QSB for the quarter ending June 30, 2007.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><strong>SIGNATURES
          </strong></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Pursuant
          to the requirements of the Securities Exchange Act of 1934, the Registrant
          has
          duly caused this Report on Form 8-K to be signed on its behalf by the
          undersigned hereunto duly authorized. </font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table align="center" bgcolor="#ffffff" border="0" cellpadding="0" cellspacing="0" width="100%">

              <tr valign="top" bgcolor="#ffffff">
                <td width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
                <td width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
                <td width="49%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
              </tr>
              <tr valign="top" bgcolor="#ffffff">
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
                <td colspan="2">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">OXIS
                    INTERNATIONAL, INC.</font></div>
                </td>
              </tr>
              <tr valign="top" bgcolor="#ffffff">
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
              </tr>
              <tr valign="top" bgcolor="#ffffff">
                <td>&#160;</td>
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">By:&#160;&#160;</font></td>
                <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">/s/
                  Marvin S. Hausman</font></td>
              </tr>
              <tr valign="top" bgcolor="#ffffff">
                <td colspan="2"><font style="FONT-FAMILY: " size="1">&#160;</font></td>
                <td align="left">
                  <hr style="COLOR: black" align="left" noshade size="2" width="80%"><font size="2">Marvin
                  S. Hausman</font></td>
              </tr>
              <tr valign="top" bgcolor="#ffffff">
                <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
                <td>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Chief
                    Executive Officer</font></div>
                </td>
              </tr>

          </table>&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman">Dated:
          April 6, 2007</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!;`6D#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***Y_Q#XJM=$0Q)B>\/2('A?=
MO3Z4`;5S=06<#3W,R11+U9S@5R&J?$&WBW1Z;`9F''FR?*OU`ZG]*XG4M5O=
M5N3-=S,Y/W4_A4'T':NCTO0[#1[6+4O$!^=S_H]F!N=SV&T<L?;\Z`"WNO%G
MB%3(EPUM:\DRY\I%'?D<G]:T8O`!G4/?:M+,QY.P9_4DY_*M!-,O_$15]73[
M'I@P8].1OF<#H92/_01^/2NE1%C1410J*`%`&``.U`''M\.M/Q\MY<@^^T_T
MK.NO"NO:.IFTN_DG1!G9&Q1O^^<X/^>*]#HH`\TTWQ[J-K($OD6YB!P3@*X_
M$<'\J[B"[L_$6E,;2ZE1'P&:%]DD9SG'M7!>.]-CLM:6>)0J72;R!_>!Y_H:
MQ]%U>;1M2CNHB2H.)4S]]>X_PH`]"N_"UXR$V?B'4T?'`FG9@?RQC]:X.ZU+
M7;&\EMI]1O4EB;:RFX;K^?XUZ_#*D\$<T;!HY%#*1W!&17'>/-#^T6HU6!/W
ML(Q,!W3U_#^7TH`XM-:U=Y%0:K>`L0,FX?`_6O1+;PM<J@^T^(-5D?OY<Y4?
MKFO*J]5\&ZW_`&KI(AF?-U;81L]67L?Z?A[T`=##'Y,,<0=WV*%W.V6.!U)[
MFDGB$\#Q%W0.I&Z-MK#Z'L:DK.UC6[/1+7SKI_F/W(E^\Y]O\:`,#7]'FT[2
MY[V'Q!J:&-<A9;DD,?3C'6N(CU?6II%CBU&_=V.%59W))_.M26?6?&VH>7&N
MRW0_=SB.,>I/<UW>A^&[+0XOW0\RX88>=QR?8>@H`Y_2O#GB&X42ZAK5[;*>
M1&L[,_X\X'ZUN?\`"-#R]O\`;.L9_O?;#G^5;E%`'F/B:/5=`O(HTUN^FCE4
MLN9V##'KS6'_`&YJ_P#T%+W_`,"'_P`:O>+M2&I>()V1LQ0_N4]\=?US5#1]
M/;5-6M[-<XD;YR!T4<D_E0!V7A_0]7U*R2\OM;U&**09CCCG;<5]22>/RHU3
MQ)'X>633]/NKB]N=W[R:[D,GEG&,#U/Z5TNNW+:9X=NIK<;6BBVQX_AS@`_A
MG]*\;)+$DDDDYR30!TEBWB/Q3<,J7DQC'WV+E(U]L#^5=!%\/("@^U:C/(^.
M=B@#]<UI>!VA;PO`(L;E9Q)C^]DG^6*Z*@#D/^$%\GYK+6+R"3LV?\,5DZG=
M>*O#.TRWQN+9SA92H<9]"2,@_P">:]%JKJ=DFHZ9<6CCB5"H]CV/YXH`\NL[
MF_\`$_B"R@OIVF7S,E3@*%'+8`XZ"N\_X0[1_P#GV'Y"N;^'=CYEY=7S#B)!
M&A]SR?T'ZUZ'0`4444`%%%%`!5>^D:+3[F1#ATB9E/H0#5BJNI?\@N[_`.N+
M_P#H)H`\]TZ]UR]L+>X;Q!=*TJ!B!%&0/TJZ!K9Y_P"$BN^?^F4?^%9^AG.B
M6?'_`"R6M..39QC(H`%36V8#_A(KO_OU'_A4HM];)Q_PD=W_`-^8_P#"I%;.
M&4U/')D88\]O>@"N+/6R<?\`"2W?_?F/_"I%T[66(SXFN_IY$?\`A5Q7['K4
MR/VSSZT`4ETO5R0/^$FO<_\`7&/_``IXT;5V.!XHO1]8(_\`"M!'R<&N=\0>
M.;30[@V<4#7=V!EE#;53ZGGG':A`:VD&_M/$UQIUUJ<U]$+-)U,J*I5B[+V'
M^S725YGX>\<VU]XL^T7\0M//MDM4(;<NX.S#)P,9W8_"O1+Z[CL+">[E(V0H
M7.3C..U%@,+Q9XE_L:W%O;8-Y*.#VC'K]?2O+9)6D=II7+L3N=F/7W)I;[59
M]3OIKIOWLLK9+'[J^P^G'2I-)TE]5U2WM6;?)(V""/E4#DG'L,T`:_A;2-1U
M&Y6[L[9!$OW+JY4^6K>JK_&1VZ#/TKT;3=!MK"9KJ1Y+N_?[]U<'+_1>RCV&
M*T+>WCM;:.WA4+%&H15'8#I4M`!1110`4444`>>?$>53?6,(/SK&S'Z$X'\C
M7$UL>*-2&J:_<3H<Q*?+C_W1_B<G\:R45G<*HRQ.`/4T`>O^%&9_"]@7SGR\
M<^@)`_2M9T61&1P&5@00>XJOIMH+#3+6TXS%$J$CN0.3^=6J`/'?$>D/HVK2
M6^"8&^>%CW4]L^HZ&HM"U9]&U:*[7)0';(H_B4]?\?PKTGQ;HZ:MHTA&U9[<
M&2-CQT'()]"/Z5Y)0!ZAKOC2ST^W"6+)<W,BAE(.50$<$_X5SND>&]1\2W1U
M'5)94@8YW-]Z3V4'H/T]*K^"K/3KS6#'?+OE";X4;[K'OD=SCG\Z]3`P,#I0
M!!9V=O86RV]K$L42]%4?K[FIZ**`"LKQ'J?]DZ'<7`;$I&R+_>/3\NOX5JUY
MQ\0=3\[4(=/1OD@7>X']\]/R'\Z`.-ZG)KOOAYIF$N-3D7D_NHLCMU8_R'YU
MPD43SS)%&NYW8*H'<G@5[7IEBNFZ9;V:'(B0*3ZGN?SS0`^_LX]0L)[27(25
M"I([>]>-ZKI=SI%\]K<IAARK=G7L17ME4=4TFSUBU-O=Q!AU5APR'U!H`\HT
M37+O0[HRP$-&W^LB)X<?X^_:O4M'UVRUNW\RVDQ(!\\3?>3_`!'O7FNO>%[S
M1)2Q'FVA/RS*.GLP[&LFWNIK.9)K>5HY4.0Z\$4`>YT5R'A[QM#?E+74ML%R
M>%DZ(Y_H?TKKZ`(+6SMK*-H[:%(E=R[!1U8]34]%%`!1110`4444`%5=2_Y!
M=W_UQ?\`]!-6JJZE_P`@N[_ZXO\`^@F@#S31I"FE6G]WRER/PK55@PR.E8ND
M'.DVO.?W8_E6C'*4XZKZ4`7HY-O!Z?RJPK8P0:I*P89'2I8Y-O!Z?RH`OQR9
M&#U_G4ZL2>:HJW1@:H7GB;3-.!$]TKR#_EG%\S9_#@?C0!T:.0PKQ'5/-&KW
MOGD^=Y[[\^NXYKT^*YU;4U#6YM[&`_QMB67UZ#Y5ZCKFJ5_X%M-0_>B]N5NB
M?GFE(DWGW''Z8IIV`\QR>:]6\1Z5<)X5AN-6O[BZN6,8\MODBCXSC8.IXQDY
M_"L2TTC1O"FO--K5T;H06ZSP($VEY"S#&W)SC;GKCUK4OD\0^*],GU6X46>F
MPH9+>SQEI<?Q'\,\_D.<T,#D,\`=AT'I7:?#JU634;NZ(R88PH]BQ_\`L:XN
MN^^&[KLU&//S9C;'M\U(#NZ***`"BBB@`KF/&>O+IFFFTA<?:[E2H']Q.Y_H
M/_K5JZUK5KHED9[ALN>(XAU<_P"'O7D6H7\^I7TEW<-F20\^P]![4`5:[#P/
MH+7EX-3N%Q;P']UD???U^@_G5?PUX1FU9DNKO,5EG([-+[#T'O7IT,,=O"D,
M**D:#:JJ,`"@!]5-1U*UTJT:YNY0B#H.['T`[FLS7_%-GHB-$")KPCY8@>GN
MQ[?S-<GI^CZIXPO!?ZC(T=IGANF1_=0>GO\`SH`;>:GJ_C.]^QV431V@/*YP
M`,_><_T_G5;Q+X6?0;>WFCE,T3C9(Q&,/U_(C^1KTRPT^UTRU6VM(5CC7TZD
M^I/<T:A8PZE836<XS'*N#['L?P-`'BMK<2VES'<POLDB8,I]Q7LFC:G'J^EP
MWD?&\8=?[K#J*\?U"QFTZ^FM)EP\38)]1V/XUN>"]<_LS5!:S-BVN2%.>BOV
M/]#_`/6H`]3HHHH`AN[F.RLYKJ4XCB0NWT`KQ.\NI+Z]FNI?]9*Y=OJ:]`^(
M.I^1IT6GHWSW#;G'^P/\3_*O.*`.K\!Z7]KUDWD@_=VJ[AQU8Y`_J?P%>G5A
M^$M,_LS0(5=<33?O9,CD$]!^`Q6%X@U,1>.],C+[8X-H?G&-QYS^&V@#N:**
M*`&R1I+&T<B*Z,,%6&017`^)/!!C5[S25++]Y[?N/]WU^G_ZJ]`HH`\&KT3P
M-X@ENU.EW3%Y(UW0N3R5'\)^G\OI7*^++:&T\37D<.`A8/M'8L`2/S-7/`L3
MOXGC9`=J1NS'VQC^9%`'J=%%%`!1110`444R6:*",R32)&@ZL[`#\S0`^JNI
M?\@N[_ZXO_Z":S+OQEX?LWV-J<4LG0)!F4D^GRYJC>>)+N]T^Y6P\/ZB\9C8
M&6Y"P+C!Y&XY/Y4`<3I$JKI\&X\&)<'\*TA(A!.X8'4GI7,VQO!I\3&5(XA&
M-HBC+N1C\OTJB;HW+-';V\]P_K.Y('_`1P/QI@=8VNV5LS)YOFL!G9$-Q'Y5
MD77C1B2MG;`>C2G/Z#_&LNYTS4EMT>3,BDX6*'HI]2!QWJ'[);VA)OW+2C_E
MWB(W9_VFZ#^=-)`2R:EK&M2^3YTLN1GRX_E4#W[8]S4MK8:5;`O?W7VF53_Q
M[6OYG+],>I'YU4EO)KB$H-EI8YYCB'#?U<_7]*JO+N7RXE\N+N,Y+?7U_E3Y
M;Z`:Y\0DOY"VJP:?R6MK9O+WG'&Y^I[9Z4Z;6;J5H+R]F8"(AK6SC8J!CH3W
M"^_4^PYK!Y/3\!7>^&?#`A9=1U)2]R?F2)^=GN?4^W;Z])T`L>%=$FU?Q.]U
MXB1IIEMUN(XGZ`%B`".P&"<>_->IX!&,<5R>BG/C.Z_[!T?_`*,>NLI`>;>)
M/!EQ:327>FQF6V8EC$OWH_H.XK!T/6)=#U-+J-=RXV2(?XE[CZU[/69J'A[2
MM38O<V<9D/\`RT7Y6_$CK^-`#M,UW3M6C#6MPI<CF)CAQ^%:-<?-\/-.=B8K
MNXC&<X.UOZ"D'@1EX76KH+Z;>WYT`=7<7=O:(7N)XXE'=V`_G7+:OX\L[8-%
MIR_:9?\`GH>$']3_`)YHB^'NG!]T]W=2GV(&?T-:UEX5T:Q(:.Q1W'\4OSG]
M>*`/.4LM<\3WAN/*EF9O^6C?*BCT!/'X"NRT3P+:6)6>_874XY"8_=K^'?\`
M'\JZP````8`Z`4M`%>ZO;33X?,N9XX4'3<<?D.]<+KOCQYE:WTD-&IX,[##'
M_=';Z]?I71R^#=%GD,DL$KN>I:9R?YTS_A"-!_Y]7_[^M_C0!Q_@[3+76-6E
M?4'\PQ@.(W;F1L]3Z@?UKU%5"*%4`*!@`#@"N?7P3H:L&6VD4CH1,V1^M:-A
MHUIILK26_F[F7:=\K/Q^)H`T***SK[1+/4;@33^=O"[?DF91CZ`^]`'(_$6&
MU\RTG5T%URC(#R5Z@D?7^=<+7K#>"=#9BS6TC$]29FR?UI/^$(T'_GU?_OZW
M^-`%7PIXJ@OK2.SO9A'=QC:&<X$H['/KZUTUU=V]E;M/<S)%$HR68_YS6'_P
MA&@_\^K_`/?UO\:4^"=#(`-M(0.F9FX_6@#SK7]4.LZO-><B,_+&I_A4<#_'
M\:K::D,NJ6D=RP6`RJ)">@7/.:]-_P"$(T'_`)]7_P"_K?XT?\(1H/\`SZO_
M`-_6_P`:`.A5E90RD%3T(Z5XSK]U]MU^^G!R&E(4^PX'Z`5Z2OA#2X4(MUGB
M;J"L[X!]<9IFD>#]-TV`BXBCO9V)W231@C\%.<4`97AOQK`\$=GJDGERJ-JS
MM]UO][T/O7:1RQS1B2)U=#T93D'\:Q+KP?H=T,_8Q$W9HF*X_#I^E9?_``@*
M0,S6.KW5N3T.,G]"*`.QK#USQ18:-$ZF19KKHL"')S_M>E8K^"-2F&R77Y73
MN&#']-U/MOAU8QD&YO)YL=D4(#_.@#A3]LUK4V*HTUU<.6(4=3_05Z?X6\/#
M0K)_-97NIL&1EZ`#HHK2T_2K'2HO+LK9(@>I'+'ZD\FKE`!1110!R']O>+;M
MO]$\++"G]ZYN1_+@TX0^.KK!DNM(LE[^5&SL/SR/UKK:*`.4_P"$5U:[_P"0
MEXJU!P1RMJJP?RS_`"J>#P)H$3B2:VDNY1_'=3,Y/U&<?I7244`5[6PL[%=M
MI:06ZXQB*,+_`"INI?\`(+N_^N+_`/H)JU574O\`D%W?_7%__030!XYI['[#
M;DCGRQ_*IY+N&TB,DCJ@)SQU)]O>LQ;IK;1XIE3<=@'L/<UBRO-=39?<\K=!
MW]@!32N!?O-<N)MR0$PQ'C(^\?Q[51")%\THR>HCZ?\`?7H/;K]*5U%LVW(:
M;^(CD)[#W_E^M2VEFC1->7;%;96[?>E/H/\`&GL!"WG2IY[G"CY5R,`^RCVS
M_G-1<<ANM6;AWG3[3(!&GW(8QT`'8>P]>YK5\.:2+J07MPH,2']VI_C;W]A5
M)I(1I^%]!$134+U/GZQ1L!\O^T??T]/Y=FK9PRFJ2L&&1TJ2-]AYZ&LQES0&
M+>,;O/;3XQ_Y$>NPKCO#QSXPNR/^@?'_`.C'KL:`,GQ+);P>'[RXNBX2&,NN
MR5HR6QA1E2#R2!7,_#_2IKS2%U;4KN\GDDD)@5[E]JJIQG&><D'KV%)\2[R2
M>+3M!MN9[V925![`X4'ZD_\`CM6_&8M=$\`_8E7=A4MX!D@EO7CKP":`.L:[
MMDC:1KB)8U.UF+@`'T)]:<\\,<!G>5%A`W&0L`H'KFO.]2\.:=H'P[>2_B::
M]$.$\QS^[E?LHZ#!.?4XJ6_8Z!\(X+:Y57N)XQ&BN,X:1BW<=54GZ$4`=5HO
MB&WUVXNS:8-I"PCCE)P97QEL#T`V_7)K3GNK>VV^?<11;CA?,<+GZ9KBI(X?
M!GA'3U@LH'UN8+#$S(-WFOR<GK@9Q^0I)O#^HW&AW%I/H5O-?SQG?>S72NYD
M(^]RN0`>@!XH`[P'(R.E0->6J@%KF$`OY8)<<MZ?7VKSS7+:XT+X9VNGZ@S/
M?M+Y42I*QVY8GL>1M&.>F:V;'P#I,&DV*ZCYDDUJ/,=C*0H/5EQTVY_'WH`Z
MXS1+*(C(@D(W!"PR1ZXIL-S!<!C!-'+M.&V,&P??%>=^#-"L]>NM5UFXCD^R
MS3M'##YA`9,YPW.2/N\9QQ5GX?6L+ZWKVHV2>58&7R($'0@$G/Y;?SH`[R:X
MAMDWSS1Q)TW2,%'ZTJ2QRQ"6.1'C(R&4Y!'UKB5>QL;[6=5OIO[:G7<0(HMZ
M6T8R=FXG:#R,C.>.]5?#,IT;X;:AJ=TJ%;AI)4B904).$48]"P_*@#J+#Q+:
M:IK<]C8LDL-NF99]WRER<!5]>C<^U'B#1+?76LX+B^E@6.3S/*C<`RX_PQ_.
ML?P'X>M;/PQ;W5U;1&ZG)N/,=!N0'[N#U'`!_&LOP?\`9CJFO^*)2_V.$O'`
MSLSG8/F)RQSG`7OW-`'HLDB1(7D=40=68X`ID%S;W2;[>>*9/[T;AA^E<AX9
MA?Q6\GB#5HQ)$79+*U8[HXU!P6QT+9R,^WTJBL:6GQ?C@TU1#&]OF[2,84_(
M3R/^^/QH`[]Y8XV17D56<X0,0"Q]!ZTU+F"65XHYHWD3[R*X)7ZCM7GFFZ9!
MXC^(>JWG[U+.R/E@QRL"[GY3SUP</T[8J30M.M#\3KUM+A6"ST^$QR!,X:0C
M!'YY_P"^:`/0998X8S)+(L:#JSG`'XTD%Q!=1^9;S1RI_>C8,/S%<G=PVY\6
MW%[?78U'RH]MOI\47F>1P,LW\*GKRV.O7@56^'H^UW&MZQ%%Y%K=7`6&$`*`
M%R<X'&?F'3OF@"'QJLFH>)](T2VNKE&N3NN429@OE_[O3HKG\*[Y55$5%`"J
M,`#L*X3P@/[<\6:SXB<;HE?[-;'M@=Q_P$+_`-]&N\H`*Y'XBW,=GX;:<2RQ
MW1<1P-',R8).2<`C/`/6NNKS?Q3_`,5)\0=,T)?FM[7#SCZ_,V?^`@#ZF@#H
MO">C&RT>TO;ZXN9;UX_-D::X<JN1TVDXX!].M;[7MJB1NUS"J2?<8R`!OIZU
MQ7Q(7[8FDZ1",W=W<83YCPO0Y'U(_*LOQIHNGV&E6EC;V<S:C)<I;V\TTFYI
M4"CE<$X4%@N"!@@X&,$@'J%0&]M1<"W-S")CTC,@W?EUKE;Z[N+O5['PG974
MB>5`KW]PC'>$`'R@]BV1D^X]ZLZYX)LM2TRVLK$1:>(9Q(9(X@6(P01GKGD'
M)/:@#J**15VH%R3@8R>II:`"BBB@`HHHH`*KWZ-)IURB*69HG``[G!JQ10!X
MM;:3J\5I'%)HFHDJH!_T<FI/[(U`3>=_85_YI&-WV8YQ7LM%`'C<>D7L;.1H
M%^#)P_\`HQYJ233+Z:'RI-"U!DQC;]F->P44`>1_V?=O`L$N@Z@T*@`+]E.`
M/:K,4-[!$L4>AZHJ(,*!;'@5ZG10!YE$VH(>=%U7'I]F/^-3>=>_]`35O_`8
M_P"->CT4`<9X6CNW\0W5U-87=M$;1(E,\13)#L<#\#76W,_V:$R^5++CC;$N
MYC^%344`><P0:I>_$,:W?Z/>I:1J4MUV`E<#`SSZEC[$U=\017NL^*M)5M,O
M#I-G)YDC^7]]^W&<D<`?B:[FB@#A/&$-_KFJZ=9+IEXVEV\XDN)!']_G'`ST
MQGGWI_C6UO[K7]$*:=<WFGV\GFRK`N<MD<'MT'?U-=Q10!P7C?3];OH](U2T
ML2T]G*SM;HV\IEE*GCK]WG&<=O6M:TU/Q!K4(3^R7TB)A^\N)I-T@'<(F!S[
MG@>AZ5T]%%P//]4M[_5/%ND,^F7_`/9&GXP\B[F=ASN()R<D*.>>I[UN^,I[
M]M#N+'3+*XN+BY386C7Y44\-D^N,C\:Z.B@#C%6\TGP##I^G:;>-?/;E-HCP
M4=OO,3GU)(_"LNYTS5['X9VUAIEI<K=/)_IB!<2;3DMC'49VCCM7H]%`'F^M
MKK=SX*MM-T_0)K6W8I&\?WI"!R3M'0;AR2<GTJSXQT_4I_">E6-GI4XA211+
M;Q,'=%484';^N.`:[^B@#E-;OM3?PU<6MCHMS'//%Y4,:X/EH1C+$'`.,X`)
M[=*AT_P_+)\-WT>.)[:[DB.\2C:3)G<<^W;/I78T4`<;X9OK_2O#<&FOH=\U
M];[E$?E[8VRQ(/F'Y<<\]_K3H-+O-`M-0U0P/?Z]?AN8$RL9[*,_P@X^N!Z5
MV%%`'$^%(+GPYX/<'2[Q]1>1W>'9RS]%Y_NX`_6J.B:7K.F^"=8DAM9TUNYD
MW$E<,02!\I[D`N?J:]$HH`\VM1KEM\/9["TT&XAG*,LTCG]Y*6;#%4^\3@]_
MPSBK]O\`VGIG@!=,L]&NUOG@**,`X+?><D'CDM@=>F<5W5%`'':2M]X=\`*+
M+3)9=0CY>"1<$N3R<#J`#V]*VO#&IW>L^'[:_O84AFEW':@(4@$@$`DGD"H-
M>9IM5TC3W9C:W3R>?&#@2!5R`2.<>W0]\UNJH50J@``8`':@"K?WILHPRVES
M<L<X6!-Q_'GBN&\&6>I6GB#5-4U?3+N.XNLE'";@H)+,.OLN*]$HH`X:U@OM
M1^(AU:^TV[ALX(#':%X^A'<X/?+G\10\%_J_Q"L[ZYTV[BTZTC*PETZO_>(S
MQR?_`!T5W-%`'G-U;Z]X?\>WFK6NE3:A:W:[?W9SP=O<9VD%>XZ5U^G_`-KW
MLZ7>H1K8Q)G99QR;V8],NPX^BCZDGMKT4`87AO4M9U-;N75=-%C&LFVW0@AR
...^[/X<\9YK=HHH`__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
